State Street’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.12M Sell
1,694,635
-89,832
-5% -$413K ﹤0.01% 2664
2025
Q4
$6.37M Buy
1,784,467
+491
+0% +$1.56K ﹤0.01% 2875
2025
Q3
$5.17M Buy
1,783,976
+7,575
+0.4% +$25.9K ﹤0.01% 2980
2025
Q2
$6.4M Buy
1,776,401
+5,713
+0.3% +$17K ﹤0.01% 2829
2025
Q1
$5.29M Sell
1,770,688
-15,390
-0.9% -$48K ﹤0.01% 2856
2024
Q4
$5.98M Buy
1,786,078
+52,592
+3% +$175K ﹤0.01% 2883
2024
Q3
$5.81M Buy
1,733,486
+11,566
+0.7% +$41.9K ﹤0.01% 2896
2024
Q2
$5.7M Buy
1,721,920
+43,537
+3% +$162K ﹤0.01% 2861
2024
Q1
$6.78M Buy
1,678,383
+48,346
+3% +$189K ﹤0.01% 2793
2023
Q4
$4.97M Buy
1,630,037
+123,800
+8% +$375K ﹤0.01% 2947
2023
Q3
$4.52M Sell
1,506,237
-27,051
-2% -$92K ﹤0.01% 2967
2023
Q2
$5.73M Sell
1,533,288
-330,049
-18% -$1.24M ﹤0.01% 2931
2023
Q1
$6.24M Sell
1,863,337
-74,393
-4% -$302K ﹤0.01% 2906
2022
Q4
$9.32M Buy
1,937,730
+42,994
+2% +$217K ﹤0.01% 2738
2022
Q3
$10.8M Buy
1,894,736
+91,368
+5% +$699K ﹤0.01% 2663
2022
Q2
$12.8M Sell
1,803,368
-68,706
-4% -$469K ﹤0.01% 2550
2022
Q1
$13.5M Sell
1,872,074
-453,379
-19% -$3.08M ﹤0.01% 2654
2021
Q4
$20.8M Buy
2,325,453
+1,222,601
+111% +$19.1M ﹤0.01% 2454
2021
Q3
$38.7M Buy
1,102,852
+141,085
+15% +$3.91M ﹤0.01% 1992
2021
Q2
$20.7M Buy
961,767
+677,244
+238% +$20.3M ﹤0.01% 2487
2021
Q1
$17.6M Buy
284,523
+61,849
+28% +$4.18M ﹤0.01% 2444
2020
Q4
$9.3M Buy
+222,674
New +$7.18M ﹤0.01% 2671

Other funds holding AVIR